Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons

Exp Cell Res. 2004 Jul 1;297(1):186-96. doi: 10.1016/j.yexcr.2004.02.028.

Abstract

The aim of this study was to evaluate whether the direct activation of the Wnt signaling pathway by its endogenous Wnt-3a ligand prevents the toxic effects induced by amyloid-beta-peptide (Abeta) in rat hippocampal neurons. We report herein that the Wnt-3a ligand was indeed able to overcome toxic effects induced by Abeta in hippocampal neurons, including a neuronal impairment on cell survival, an increase in glycogen synthase kinase-3beta (GSK-3beta) and tau phosphorylation, a decrease in cytoplasmic beta-catenin and a decrease in the expression of the Wnt target gene engrailed-1. We further demonstrate that Wnt-3a protects hippocampal neurons from apoptosis induced by Abeta. Our results support the hypothesis that a loss of function of Wnt signaling may play a role in the progression of neurodegenerative diseases such as Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Peptides / toxicity
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • Culture Media, Conditioned / pharmacology
  • Cytoskeletal Proteins / drug effects
  • Cytoskeletal Proteins / metabolism
  • Glycogen Synthase Kinase 3 / drug effects
  • Glycogen Synthase Kinase 3 / metabolism
  • Glycogen Synthase Kinase 3 beta
  • Hippocampus / cytology
  • Hippocampus / embryology
  • Homeodomain Proteins / drug effects
  • Homeodomain Proteins / metabolism
  • Ligands
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / metabolism*
  • Nerve Degeneration / prevention & control
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurons / pathology
  • Neuroprotective Agents / metabolism*
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Phosphorylation / drug effects
  • Proteins / agonists
  • Proteins / metabolism*
  • Proteins / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Trans-Activators / drug effects
  • Trans-Activators / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / physiology
  • Wnt Proteins
  • Wnt3 Protein
  • beta Catenin
  • tau Proteins / drug effects
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • Ctnnb1 protein, rat
  • Culture Media, Conditioned
  • Cytoskeletal Proteins
  • Homeodomain Proteins
  • Ligands
  • Nerve Tissue Proteins
  • Neuroprotective Agents
  • Proteins
  • Trans-Activators
  • Wnt Proteins
  • Wnt3 Protein
  • beta Catenin
  • engrailed 2 protein
  • tau Proteins
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, rat
  • Glycogen Synthase Kinase 3